SAFE score yielded a better performance than FIB-4 and NFS in predicting significant fibrosis among Asian NAFLD patients

被引：0

作者：

Sripongpun, Pimsiri ^{[1
,2
]}

Treeprasertsuk, Sombat ^{[3
]}

Charatcharoenwitthaya, Phunchai ^{[4
]}

Kaewdech, Apichat ^{[1
]}

Chamroonkul, Naichaya ^{[1
]}

Chan, Wah-Kheong ^{[5
]}

Ng, Cheng Han ^{[6
]}

Muthiah, Mark ^{[6
]}

Dan, Yock-Young ^{[6
]}

Kim, W. Ray ^{[2
]}

机构：

[1] Prince Songkla Univ, Internal Med, Hat Yai, Thailand

[2] Stanford Univ, Sch Med Gastroenterol & Hepatol, Stanford, CA USA

[3] Chulalongkorn Univ, Bangkok, Thailand

[4] Mahidol Univ, Siriraj Hosp, Salaya, Nakhon Pathom, Thailand

[5] Univ Malaya, Kuala Lumpur, Malaysia

[6] Natl Univ Singapore, Singapore, Singapore

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-503

引用

下载

页码：S721 / S721

页数：1

共 50 条

[21] FIB-8 SCORE: A MODEL INCORPORATING ADDITIONAL COMMON VARIABLES INTO THE FIB-4 SCORE AFFORDS BETTER PREDICTION OF SIGNIFICANT FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE
Sripongpun, Pimsiri
Mannalithara, Ajitha
Kim, Donghee
Touros, Alexis
Kim, W. Ray
HEPATOLOGY, 2019, 70 : 1037A - 1038A
[22] FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients
Mallet, Vincent
Parlati, Lucia
Vallet-Pichard, Anais
Terris, Benoit
Tsochatzis, Emmanuel
Sogni, Philippe
Pol, Stanislas
PRESSE MEDICALE, 2019, 48 (12): : 1484 - 1488
[23] MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Yamamura, Sakura
Eslam, Mohammed
Kawaguchi, Takumi
Tsutsumi, Tsubasa
Nakano, Dan
Yoshinaga, Shinobu
Takahashi, Hirokazu
Anzai, Keizo
George, Jacob
Torimura, Takuji
LIVER INTERNATIONAL, 2020, 40 (12) : 3018 - 3030
[24] The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study
Tutunchi, Helda
Naeini, Fatemeh
Ebrahimi-mameghani, Mehrangiz
Mobasseri, Majid
Naghshi, Sina
Ostadrahimi, Alireza
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
[25] THE WAIST-TO-HIP RATIO ADDS LITTLE TO THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE IN PREDICTING SIGNIFICANT FIBROSIS AMONG PATIENTS WITH NAFLD
Sripongpun, Pimsiri
Charu, Vivek
Kim, Sun H.
Kim, W. Ray
HEPATOLOGY, 2022, 76 : S792 - S793
[26] Performance of novel collagen turnover biomarkers in relation to FIB-4 to detect advanced fibrosis in NAFLD
Hegmar, Hannes
Moller, Thomas
Nasr, Patrik
Vessby, Johan
Kechagias, Stergios
Nyhlin, Nils
Marschall, Hanns-Ulrich
Borssen, Asa Danielsson
Karsdal, Morten
Leeming, Diana
Ekstedt, Mattias
Hagstrom, Hannes
JOURNAL OF HEPATOLOGY, 2023, 78 : S707 - S707
[27] New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
Torres, Louise
Schuch, Alice
Longo, Larisse
Valentini, Bruna Bressan
Galva, Gabriela Schneider
Luchese, Eduardo
Pinzon, Carlos
Bartels, Rodrigo
Alvares-da-Silva, Mario Reis
ANNALS OF HEPATOLOGY, 2023, 28 (01)
[28] Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients
Lima, Rodrigo Vieira Costa
Stefano, Jose Tadeu
Malta, Fernanda de Mello
Pinho, Joao Renato Rebello
Carrilho, Flair Jose
Arrese, Marco
Oliveira, Claudia P.
BIOMEDICINES, 2021, 9 (12)
[29] FIB-4 AND NAFLD FIBROSIS SCORES ARE POOR PREDICTORS FOR LIVER FIBROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Barbara, Mary
Alkhouri, Naim
Hashim, Mahmoud
Hassan, Manal M.
Jalal, Prasun K.
HEPATOLOGY, 2020, 72 : 915A - 916A
[30] Fibroscan-based score for detection of active nash and significant fibrosis is better than fib-4 in 361 chronic hepatitis B patients with non-alcoholic fatty liver disease
Chi, Xiaoling
Shi, Meijie
Xiao, Huanming
Zhao, Pengtao
Xie, Yubao
Jiang, Junmin
Cai, Gaoshu
Cao, Minling
Liang, Hongcai
Li, Yingxian
Chen, Huijun
Zhang, Chaozhen
Li, Sheng
Wu, Shuduo
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E761 - E762

← 1 2 3 4 5 →